Q2 2025 Earnings Conference Call March 6, 2025 5:30 PM ETCompany ParticipantsBill Ulrey - Investor RelationsSamuel Jonas - ...

NEWARK, N.J. (AP) — NEWARK, N.J. (AP) — IDT Corp. (IDT) on Thursday reported net income of $20.3 million in its fiscal second quarter. The Newark, New Jersey-based company said it had net income of 80 ...

NEWARK, NJ, Feb. 25, 2025 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications solutions, has scheduled its report of ...

Record levels of gross profit +16%; income from operations +77%; Adjusted EBITDA * +56% GAAP EPS increased to $0.80 from $0.57; Non-GAAP EPS * increased to $0.84 from $0.67 IDT raised its ...

The finances of the state-owned Independent Development Trust (IDT) came under scrutiny as the entity is engaged in a balancing act of managing social infrastructure projects while grappling with ...

NEWARK, NJ, Feb. 25, 2025 (GLOBE NEWSWIRE) -- IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and traditional communications solutions, has scheduled its report of ...

Innocan Pharma Ltd. Each Warrant is exercisable into one Common Share at a price of CAD$0.26 for a period of four (4) years from the date of issuance. Innocan intends to use the proceeds of the ...

Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...

Our vision for our lead asset NOX-A12 remains clear: to secure approval for its use in glioblastoma patients through a strategic partnership with a pharmaceutical company, supported by ...

HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its ...

Nvidia exited its positions in several AI stocks in Q4, but maintained its stake in Recursion Pharmaceuticals. Many investors seemed to view this as a vote of confidence from Nvidia for Recursion.